BioStock: Saniona strengthens US executive team with three industry veterans

Report this content

Since American Rami Levin took over as new CEO for Saniona in January, the company has had the clear ambition to build a full-fledged organisation in the United States. The establishment of the head office took a big step forward with the appointment of three central positions, at the same time as pivotal clinical studies in two rare eating disorders are approaching. BioStock contacted the CEO for a comment on how the new competencies strengthen the company’s goal of reaching the market with the primary drug candidate Tesomet. 

Read the full interview with Rami Levin at biostock.se:

https://www.biostock.se/en/saniona-strengthens-us-executive-team-with-three-industry-veterans/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
 


Subscribe

Quick facts

BioStock: Saniona strengthens US executive team with three industry veterans
Tweet this

Quotes

As we continue to advance Tesomet through late-stage clinical trials, I anticipate adding additional key roles and building out key functions to be able to achieve our goals
Rami Levin, CEO Saniona